Clinical Trials Logo

Citation(s)

  •   Abramowitz JS, Deacon BJ, Olatunji BO, Wheaton MG, Berman NC, Losardo D, Timpano KR, McGrath PB, Riemann BC, Adams T, Björgvinsson T, Storch EA, Hale LR
    Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the Dimensional Obsessive-Compulsive Scale. Psychol Assess. 2010 Mar;22(1):180-98. doi: 10.1037/a0018260.
  •   Abramowitz JS, Foa EB, Franklin ME
    Exposure and ritual prevention for obsessive-compulsive disorder: effects of intensive versus twice-weekly sessions. J Consult Clin Psychol. 2003 Apr;71(2):394-8.
  •   Abramowitz JS, Franklin ME, Zoellner LA, DiBernardo CL
    Treatment compliance and outcome in obsessive-compulsive disorder. Behav Modif. 2002 Sep;26(4):447-63.
  •   Abramowitz JS, Taylor S, McKay D
    Obsessive-compulsive disorder. Lancet. 2009 Aug 8;374(9688):491-9. doi: 10.1016/S0140-6736(09)60240-3.
  •   Abramowitz JS, Taylor S, McKay D
    Potentials and limitations of cognitive treatments for obsessive-compulsive disorder. Cogn Behav Ther. 2005;34(3):140-7. Review.
  •   Beck, A
    T. (1996). Beck Depression Inventory (2nd ed.). San Antonio, TX: The Psychological Corporation.
  •   Eifert, G
    H., & Forsyth, J. P. (2005). Acceptance and commitment therapy for anxiety disorders: A practitioner's treatment guide to using mindfulness, acceptance, and values-based behavior change strategies. Oakland, CA US: New Harbinger Publications.
  •   Foa EB, Kozak MJ, Goodman WK, Hollander E, Jenike MA, Rasmussen SA
    DSM-IV field trial: obsessive-compulsive disorder. Am J Psychiatry. 1995 Jan;152(1):90-6. Erratum in: Am J Psychiatry 1995 Apr;152(4):654.
  •   Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X
    Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 2005 Jan;162(1):151-61.
  •   Franklin, M
    E. (2005). Combining serotonin medication with cognitive-behavior therapy: Is it necessary for all OCD patients. In J. Abramowitz & A. Houts (eds.). Concepts and controversies in obsessive-compulsive disorder (pp. 377-389). New York: Springer.
  •   Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS
    The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989 Nov;46(11):1006-11.
  •   Hayes, S
    C. (2008). Climbing our hills: A beginning conversation on the comparison of acceptance and commitment therapy and traditional cognitive behavioral therapy. Clinical Psychology: Science and Practice, 15, 286-295.
  •   Hayes, S
    C., Strosahl, K. D., & Wilson, K. G. (1999). Acceptance and commitment therapy: An experiential approach to behavior change. New York, NY US: Guilford Press.
  •   Jacobson NS, Truax P
    Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991 Feb;59(1):12-9.
  •   Kelley, M
    L., Heffer, R. W., Gresham, F. M., & Elliott, S. N. (1989). Development of a modified Treatment Evaluation Inventory. Journal of Psychopathology and Behavioral Assessment, 11, 235-247.
  •   Leung AW, Heimberg RG
    Homework compliance, perceptions of control, and outcome of cognitive-behavioral treatment of social phobia. Behav Res Ther. 1996 May-Jun;34(5-6):423-32.
  •   Levitt, J
    T., Brown, T. A., Orsillo, S. M., & Barlow, D. H. (2004). The effects of acceptance versus suppression of emotion on subjective and psychophysiological response to carbon dioxide challenge in patients with panic disorder. Behavior Therapy, 35, 747-766.
  •   Marcks BA, Woods DW
    A comparison of thought suppression to an acceptance-based technique in the management of personal intrusive thoughts: a controlled evaluation. Behav Res Ther. 2005 Apr;43(4):433-45.
  •   Marcks BA, Woods DW
    Role of thought-related beliefs and coping strategies in the escalation of intrusive thoughts: an analog to obsessive-compulsive disorder. Behav Res Ther. 2007 Nov;45(11):2640-51. Epub 2007 Jul 5.
  •   Masedo AI, Rosa Esteve M
    Effects of suppression, acceptance and spontaneous coping on pain tolerance, pain intensity and distress. Behav Res Ther. 2007 Feb;45(2):199-209. Epub 2006 Mar 29.
  •   Páez-Blarrina M, Luciano C, Gutiérrez-Martínez O, Valdivia S, Ortega J, Rodríguez-Valverde M
    The role of values with personal examples in altering the functions of pain: comparison between acceptance-based and cognitive-control-based protocols. Behav Res Ther. 2008 Jan;46(1):84-97. Epub 2007 Oct 22.
  •   Simpson HB, Zuckoff AM, Maher MJ, Page JR, Franklin ME, Foa EB, Schmidt AB, Wang Y
    Challenges using motivational interviewing as an adjunct to exposure therapy for obsessive-compulsive disorder. Behav Res Ther. 2010 Oct;48(10):941-8. doi: 10.1016/j.brat.2010.05.026. Epub 2010 Jun 1.
  •   Steketee G, Chambless DL, Tran GQ, Worden H, Gillis MM
    Behavioral avoidance test for obsessive compulsive disorder. Behav Res Ther. 1996 Jan;34(1):73-83.
  •   Twohig MP, Hayes SC, Masuda A
    Increasing willingness to experience obsessions: acceptance and commitment therapy as a treatment for obsessive-compulsive disorder. Behav Ther. 2006 Mar;37(1):3-13. Epub 2006 Feb 21.
  •   Twohig MP, Hayes SC, Plumb JC, Pruitt LD, Collins AB, Hazlett-Stevens H, Woidneck MR
    A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder. J Consult Clin Psychol. 2010 Oct;78(5):705-16. doi: 10.1037/a0020508.
  •   Vogel, P
    A., Stiles, T. C., & Gotestam, K. G. (2004). Adding cognitive therapy elements to exposure therapy for obsessive-compulsive disorder: a controlled study. Behavioural and Cognitive Psychotherapy, 32, 275-290.
  •   Woods, C
    M., Chambless, D. L., & Steketee, G. (2002). Homework compliance and behavior therapy outcome for panic with agoraphobia and obsessive compulsive disorder. Cognitive Behaviour Therapy, 31, 88-95.

Combining Acceptance and Commitment Therapy With Exposure and Response Prevention to Enhance Treatment Engagement in Obsessive-Compulsive Disorder

Details for clinical trial NCT03343106